Dashboard
Manage Tickers

BHVN Biohaven Ltd.

NYSE biohavenpharma.com


$ 8.52 $ 0.05 (0.65 %)    

Thursday, 06-Nov-2025 19:38:56 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 613.36 $ -9.99 (-1.61 %)
DIA $ 470.23 $ -2.78 (-0.59 %)
SPY $ 671.96 $ -6.30 (-0.93 %)
TLT $ 89.61 $ 0.21 (0.23 %)
GLD $ 367.27 $ -1.11 (-0.3 %)
$ 8.53
$ 8.47
$ 8.45 x 1,000
$ 8.95 x 25
$ 8.15 - $ 9.05
$ 7.80 - $ 54.68
8,644,005
na
581.41M
$ 1.96
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-11-2025 06-30-2025 10-Q
2 05-12-2025 03-31-2025 10-Q
3 03-03-2025 01-01-1970 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-09-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 02-29-2024 12-31-2023 10-K
8 11-14-2023 09-30-2023 10-Q
9 07-31-2023 06-30-2023 10-Q
10 05-12-2023 03-31-2023 10-Q
11 03-23-2023 12-31-2022 10-K
12 11-09-2022 09-30-2022 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

bernstein-downgrades-biohaven-to-market-perform-lowers-price-target-to-9
Bernstein Downgrades Biohaven to Market Pe...
11/06/2025 17:57:35

Bernstein analyst William Pickering downgrades Biohaven (NYSE:BHVN) from Outperform to Market Perform and lowers the price t...

rbc-capital-maintains-sector-perform-on-biohaven-lowers-price-target-to-9
RBC Capital Maintains Sector Perform on Bi...
11/06/2025 15:38:54

RBC Capital analyst Leonid Timashev maintains Biohaven (NYSE:BHVN) with a Sector Perform and lowers the price target from $1...

btig-maintains-buy-on-biohaven-lowers-price-target-to-16
BTIG Maintains Buy on Biohaven, Lowers Pri...
11/06/2025 09:52:36

BTIG analyst Thomas Shrader maintains Biohaven (NYSE:BHVN) with a Buy and lowers the price target from $33 to $16.

william-blair-downgrades-biohaven-to-market-perform
William Blair Downgrades Biohaven to Marke...
11/05/2025 23:52:41

William Blair analyst Myles Minter downgrades Biohaven (NYSE:BHVN) from Outperform to Market Perform.

td-cowen-maintains-buy-on-biohaven-lowers-price-target-to-15
TD Cowen Maintains Buy on Biohaven, Lowers...
11/05/2025 18:33:56

TD Cowen analyst Tyler Van Buren maintains Biohaven (NYSE:BHVN) with a Buy and lowers the price target from $50 to $15.

biohaven-stock-hits-52-week-low-cuts-rd-spending-after-fda-rejection
Biohaven Stock Hits 52-Week Low, Cuts R&D ...
11/05/2025 17:53:02

Biohaven stock plunged after the FDA rejected Vyglxia for spinocerebellar ataxia, prompting major R&D cuts and a William Bl...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
11/05/2025 17:05:53

crude-oil-down-1-solid-power-shares-spike-higher
Crude Oil Down 1%; Solid Power Shares Spik...
11/05/2025 17:05:00

dow-surges-100-points-mcdonalds-posts-downbeat-earnings
Dow Surges 100 Points; McDonald's Posts Do...
11/05/2025 15:19:24

super-micro-computer-posts-downbeat-q1-results-joins-pinterest-axon-enterprise-and-other-big-stocks-moving-lower-in-wednesdays-pre-market-session
Super Micro Computer Posts Downbeat Q1 Res...
11/05/2025 13:45:15

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
11/05/2025 12:05:48

why-teradata-shares-are-trading-higher-by-around-15-here-are-20-stocks-moving-premarket
Why Teradata Shares Are Trading Higher By ...
11/05/2025 10:09:59

reported-earlier-biohaven-receives-fda-complete-response-letter-for-vyglxia-following-positive-real-world-evidence-showing-5070-slowing-of-spinocerebellar-ataxia-disease-progression
Reported Earlier, Biohaven Receives FDA Co...
11/05/2025 08:16:03

kimberly-clark-vertex-and-other-big-stocks-moving-lower-in-mondays-pre-market-session
Kimberly-Clark, Vertex And Other Big Stock...
11/03/2025 13:14:55

Core News & Articles
10 Health Care Stocks With Whale Alerts In...
09/29/2025 17:35:29

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and...

this-protagonist-therapeutics-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-wednesday
This Protagonist Therapeutics Analyst Begi...
09/17/2025 12:15:15

citigroup-initiates-coverage-on-biohaven-with-buy-rating-announces-price-target-of-28
Citigroup Initiates Coverage On Biohaven w...
09/17/2025 11:30:06

Citigroup analyst Samantha Semenkow initiates coverage on Biohaven (NYSE:BHVN) with a Buy rating and announces Price Target ...

ubs-maintains-buy-on-biohaven-lowers-price-target-to-26
UBS Maintains Buy on Biohaven, Lowers Pric...
09/16/2025 12:43:46

UBS analyst Ashwani Verma maintains Biohaven (NYSE:BHVN) with a Buy and lowers the price target from $27 to $26.

raymond-james-initiates-coverage-on-biohaven-with-strong-buy-rating-announces-price-target-of-75
Raymond James Initiates Coverage On Biohav...
09/03/2025 16:44:36

Raymond James analyst Chris Raymond initiates coverage on Biohaven (NYSE:BHVN) with a Strong Buy rating and announces Price ...

biohaven-advances-toward-potential-first-fda-approved-therapy-for-spinocerebellar-ataxia-fda-drops-advisory-meeting
Biohaven Advances Toward Potential First F...
08/22/2025 13:14:12

Biohaven shares rise as FDA removes advisory committee meeting for troriluzole in spinocerebellar ataxia, with decision expecte...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION